NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum Classical Workflow for Clinical Data Analytic

Platform successfully processes real-world clinical data through an integrated quantum-enabled analytical workflow, generating biologically relevant analytical insights Toronto, Ontario – TheNewswire - July 31, 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company, today announced another technological milestone achieved by its quantum platform for clinical data analytics (the “ Platform ” ). The Platform has successfully demonstrated a complete end-to-end hybrid quantum-classical workflow capable of processing real-world clinical data through a fully integrated analytical framework, from secure data ingestion and preparation, through quantum-enabled analytical processing, to the generation of biologically and clinically interpretable insights. The demonstrated workflow showcases the Platform's ability to process real-world clinical datasets using an integrated analytical framework that combines data preparation, quantum-enabled analysis and biologically relevant interpretation. The workflow was executed within a quantum simulation environment designed to emulate quantum computational processes relevant to the Platform's anal

Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois